Related references
Note: Only part of the references are listed.Bidirectional effects of IL-10+ regulatory B cells in Ldlr-/- mice
Hidde Douna et al.
ATHEROSCLEROSIS (2019)
T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway
Jose-Ignacio Rodriguez-Barbosa et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet
Meritxell Nus et al.
NATURE MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
Christodoulos Stefanadis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses
Marta Spodzieja et al.
PLOS ONE (2017)
Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis
A. C. Foks et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Amanda C. Foks et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Novel B-cell subsets in atherosclerosis
Hidde Douna et al.
CURRENT OPINION IN LIPIDOLOGY (2016)
Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis
Eduardo Huarte et al.
JOURNAL OF IMMUNOLOGY (2016)
The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis
Bin Yang et al.
PLOS ONE (2016)
Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells
Sabrina Gruber et al.
CELL REPORTS (2016)
Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses
Zi Ye et al.
SCIENTIFIC REPORTS (2016)
Regulatory B Cell-Specific Interleukin-10 Is Dispensable for Atherosclerosis Development in Mice
Andrew P. Sage et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The expanding family of regulatory B cells
Claudia Mauri et al.
INTERNATIONAL IMMUNOLOGY (2015)
Fluorescent activated cell sorting: An effective approach to study dendritic cell subsets in human atherosclerotic plaques
Ilse Van Brussel et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)
Differences in B7 and CD28 family gene expression in the peripheral blood between newly diagnosed young-onset and adult-onset type 1 diabetes patients
K. Pruul et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10
Asa C. Strom et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Treating Atherosclerosis With Regulatory T Cells
Amanda C. Foks et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
A novel nanoparticle containing MUG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis
Bangqing Yuan et al.
MOLECULAR IMMUNOLOGY (2014)
An Agonistic Anti-BTLA mAb ( 3C10) Induced Generation of IL-10-Dependent Regulatory CD4+T Cells and Prolongation of Murine Cardiac Allograft
Masateru Uchiyama et al.
TRANSPLANTATION (2014)
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Peter Libby et al.
IMMUNITY (2013)
BAFF Receptor mAb Treatment Ameliorates Development and Progression of Atherosclerosis in Hyperlipidemic ApoE-/- Mice
Tin Kyaw et al.
PLOS ONE (2013)
IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity
Giang T. Tran et al.
BLOOD (2012)
Depletion of B2 but Not B1a B Cells in BAFF Receptor-Deficient ApoE-/- Mice Attenuates Atherosclerosis by Potently Ameliorating Arterial Inflammation
Tin Kyaw et al.
PLOS ONE (2012)
B1a B Lymphocytes Are Atheroprotective by Secreting Natural IgM That Increases IgM Deposits and Reduces Necrotic Cores in Atherosclerotic Lesions
Tin Kyaw et al.
CIRCULATION RESEARCH (2011)
A Functional Polymorphism in B and T Lymphocyte Attenuator Is Associated with Susceptibility to Rheumatoid Arthritis
Mie Oki et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice
Qing Ding et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression
Joern C. Albring et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
B cell depletion reduces the development of atherosclerosis in mice
Hafid Ait-Oufella et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator
Yoshihiro Oya et al.
ARTHRITIS AND RHEUMATISM (2008)
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses
Koichi Yanaba et al.
IMMUNITY (2008)
Atherosclerotic Plaque Stability-What Determines the Fate of a Plaque?
Bente Halvorsen et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2008)
Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malarial
Bernd Lepenies et al.
JOURNAL OF IMMUNOLOGY (2007)
Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells
X.-F. Wang et al.
TISSUE ANTIGENS (2007)
Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells
C Krieg et al.
JOURNAL OF IMMUNOLOGY (2005)
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator
JR Sedy et al.
NATURE IMMUNOLOGY (2005)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
P Han et al.
JOURNAL OF IMMUNOLOGY (2004)
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
N Watanabe et al.
NATURE IMMUNOLOGY (2003)
Share Paper
